Study Objectives: Anxiety is thought to be a significant contributor to chest pain symptoms in approximately 40% of patients with low risk chest pain seen in the emergency department (ED). The validated Hospital Anxiety Depression Scale -Anxiety subscale (HADS-A) has been used as an anxiety screening tool in this population. These patients have been shown to have persistent anxiety symptoms at follow-up and significantly higher ED utilization. The objective of this study was to determine the prevalence of abnormal anxiety levels in a cohort of low-risk chest pain patients and characterize their comorbid psychological contributors. We hypothesized that those with abnormal anxiety scores would have worse concomitant depression, optimism and pain catastrophizing scores in addition to experiencing more life trauma.
Methods: This was a pre-planned secondary analysis of a single-center, prospective observational cohort study of ED subjects with low risk chest pain. Eligible subjects between 18 and 70 years old with no history of acute coronary syndrome (ACS) and a physician-reported HEART score < 4, were enrolled. The HADS-A was used to stratify participants into 2 groups: Low Anxiety (score<8) and High Anxiety (score8). Outcomes assessed included concomitant depression via the Hospital Anxiety Depression ScaleDepression subscale (HADS-D), previous trauma (Traumatic Life Events Questionnaire), optimism (Life Optimism Test-Revised), and pain catastrophizing (Pain Catastrophizing Scale). These groups were analyzed and compared using t-tests for continuous data and chi-square for proportional/ categorical data.
Results: Of 442 screened subjects, 304 met enrollment criteria and 163 (36.8%) gave informed consent. Seventy-six (47%) were stratified into the High Anxiety group with a score8. There were no differences in baseline demographics between groups. Overall, there was a moderate positive correlation between HADS-A and HADS-D scores with a Pearson's R of 0.519. Thirty percent of all subjects had abnormal depression scores 8 on the HADS-D and 35 subjects (45%) had both abnormal anxiety as well as depression. Mean depression scores were significantly different between the low anxiety and high anxiety groups (3.64, 95% CI 2.17 to 5.10). Traumatic experiences of assault with a weapon (p¼0.000), physical assault (p¼0.012), sexual assault (p¼0.046), witnessing fire (p¼0.034), natural disaster (p¼0.035) were all associated with abnormal levels of anxiety. However, only sexual assault (p¼0.030) and other unwanted sexual encounters (p¼0.040) were associated with abnormal levels of depression. Optimism was negatively correlated with both anxiety (R¼-0.489) and depression (R¼-0.504). Additionally, optimism was significantly lower for subjects with either abnormal anxiety (mean difference of 3.86, 95% CI 2.46 to 5.26) or abnormal depression (mean difference 4.32, 95% CI 2.80 to 5.83). Pain catastrophizing was also significantly higher in subjects with either abnormal anxiety or depression (p¼0.000).
Conclusions: The prevalence of abnormal levels of anxiety in our low risk chest pain cohort was 47%. These patients were more likely to have concurrent symptoms of depression, multiple traumatic exposures, a less optimistic outlook, and a pain catastrophizing phenotype. These data indicate there may be an opportunity to address these problems in many low risk chest pain patients as a best practice.
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A Data-Driven Approach to Identifying Acute Coronary Syndrome in the Emergency Department Sutton N, Smith S, Plumley J, Tamayo-Sarver J, Butler I/Vituity, Emeryville, CA Study Objectives: Develop a data-driven cardiac risk stratification tool using advanced analytics and machine learning.
Methods: Using historical patient data from 2 large community health centers, we created a gradient boosted algorithm using a dataset of 677,577 patient encounters. We then applied this algorithm to a smaller dataset of 3,375 patients who were treated through a chest pain model centered on the HEART score. We then analyzed the performance of our data-driven model against the performance of the prevalent HEART model.
Results: Using MACE at 30 days as our primary outcome, our data-driven model has a higher sensitivity (0.986 versus 0.942) and lower negative likelihood ratio (0.015 versus 0.061) for identifying low-risk patients appropriate for outpatient follow-up. This corresponds with a lower "miss rate" of patients identified as low-risk but who go on to have MACE within 30 days. Our datadriven model also demonstrates a substantial increase in positive predictive value for high risk patients from 0.453 patients in the HEART model to 0.705 in our data-driven model.
Conclusions: Our data-driven model has potential to improve identification of patient's appropriate for discharge and outpatient follow-up, while also increasing the ability of physicians to identify patients who are at highest risk for MACE within 30 days. This tool could enhance physician decisionmaking to more effectively disposition chest pain patients who present to the emergency department.
Impact of a Standardized Chest Pain Clinical Pathway and Electronic Clinical Decision Support Tool to Improve Chest Pain Management in the Emergency Department
Matuskowitz A, Abukhdeir HF/Medical University of South Carolina, Charleston, SC Study Objectives: Chest pain management in the United States is expensive and inefficient. The HEART Pathway is an accelerated diagnostic pathway that identifies low risk patients presenting to the emergency department (ED) with chest pain who can forgo further cardiac testing. Studies demonstrate that it safely reduces hospital admissions, length of stay, and downstream cardiac testing. However, management recommendations for moderate risk patients remain unclear. We developed a modified HEART Pathway that recommends advanced imaging (coronary CT angiogram, triple-rule-out CT angiogram, or stress testing) for moderate risk patients with the aim to identify additional patients safe for discharge. We also developed an optional electronic clinical decision support (CDS) tool embedded in the electronic medical record that gives management recommendations based on the modified HEART Pathway. The objectives included whether the modified HEART Pathway safely reduces hospital admissions, whether the CDS tool affects imaging and discharge rates, and whether advanced imaging identifies additional acute coronary disease.
Methods: We developed and educated ED providers on the modified HEART Pathway in July 2016. In September 2017, we implemented the optional electronic CDS tool. We retrospectively enrolled 18,746 patients presenting to the ED with chest pain and had at least one troponin ordered between January 2013 to April 2018. Patients were categorized into pre-implementation (n¼11,208), modified HEART Pathway education (n¼3,614), and CDS tool use (n¼2,045) groups. We retrospectively analyzed disposition, CDS tool use, and advanced imaging use.
Results: Overall, discharge rates remained unchanged in the preimplementation, modified HEART Pathway education, and CDS tool groups, 71.7% (8,035/11,208) versus 70.6% (2,552/3,614) versus 71.9% (1,450/2,017), (p¼0.42). Only 14.5% (296/2,045) of providers used the CDS tool. However, when used, the CDS tool trended towards increasing discharge rates, 75.5% (222/ 294) versus 71.3% (1,228/1,723), (p¼0.135). Also, advanced imaging, in general, led to an increase in admission rates, 31.1% (1,140/3,667) versus 27.9% (4,138/ 14,845), (p<0.01).
Conclusions: Our pilot data suggests that education alone may not reduce admission rates, but advanced CDS tools that incentivize providers to use the modified HEART Pathway may. Our pilot data demonstrates significantly higher baseline discharge rates than previous studies (75.5% versus w50%), which may have limited the effect of the modified HEART Pathway on discharge rates. Additionally, there was a 3.2% increase in admissions when advanced imaging was used. This suggests that advanced imaging -when used for moderate risk patients -identifies additional acute coronary disease. Future studies should focus on developing CDS tools that increase adherence to the modified HEART Pathway, evaluating adverse event rates in moderate risk patients, and improve guidance on advanced imaging in moderate risk patients. Study Objectives: The objective of this study was to examine the diurnal timing of NSTEMI versus STEMI presentations in the emergency department.
Methods: Retrospective records of patients with myocardial infarctions presenting to a multi-hospital system were retrieved from electronic medical records for the years 2013-2017. NSTEMI and STEMI cases were identified based on diagnosis codes, and arrival times to the emergency department were categorized into 4 time periods (12AM -5:59AM, 6AM -11:59AM, 12PM -5:59PM, 6PM -11:59PM). Proportions of NSTEMI in each quartile were calculated with 95% CI. A Chi Square test with a Bonferroni adjustment (a¼0.0125) for multiple comparisons was used to compare the proportion of NSTEMI cases across time periods.
Results: We identified 18,663 myocardial infarctions, which included 16,268 NSTEMIs and 2,395 STEMs, from 11 hospitals in the Southeastern United States. In this cohort, the highest proportion of STEMIs (33.07%) and NSTEMIs (36.06%) occurred between 12PM -5:59PM. A Chi Square test of independence revealed an overall significant difference in the proportion of NSTEMIs across all time periods (X 2 ¼11.70, df¼3, p¼0.008), while pairwise tests demonstrated a significantly higher proportion of NSTEMIs versus STEMIs that arrived to the emergency department during the third time period (12PM -5:59PM) compared to the second (6AM -11:59AM, p¼0.009). Two-sided Cochran Armitage test of the time quartiles shows there is a significant trend in proportion of MI's that are STEMIs (Z¼2.088, p¼0.04), and one-sided analysis shows it is a decreasing trend (Z¼2.088, p¼0.02).
Conclusions: To our knowledge, this is the first study to examine the circadian activity of NSTEMIs versus STEMIs. This retrospective analysis suggests that the proportion of NSTEMIs versus STEMIs is higher in the afternoon between the hours of 12PM-5:59PM. This observed difference in NSTEMI versus STEMI presentations may be due to the underlying pathophysiology, diurnal patient factors such as physical activity and convenience, or other confounding factors.
